The University of Chicago Header Logo

Anjana Pillai

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Gastroenterology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Miami School of Medicine, Miami, FLMD
    University of Illinois Chicago, Chicago, ILInternal Medicine
    Cleveland Clinic , Cleveland, OHGastroenterology and Hepatology
    Northwestern Memorial Hospital, Chicago, ILTransplant Hepatology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shah N, Pillai A, Shah N, Pillai A. Reimagining Liver Cancer Allocation: Defining a New Vision. Gastroenterology. 2025 Apr; 168(4):650-651. PMID: 39756523.
      Citations:    Fields:    
    2. Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen NJ, Shaukat A, Sirlin CB, Verna E, Wani S, Wilson Woods A, Yang JD, Parikh ND, Singal AG, Quirk L, Boike J, Chernyak V, Feng Z, Giamarqo G, Kanwal F, Ioannou GN, Manes S, Marrero JA, Mehta N, Pillai A, Shaheen NJ, Shaukat A, Sirlin CB, Verna E, Wani S, Wilson Woods A, Yang JD, Parikh ND. Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology. 2024 Dec 18. PMID: 39699563.
      Citations:    Fields:    
    3. Manivannan A, Pillai A, Liapakis A, Parikh ND, Kumar V, Verna EC, Salgia R, Wu T, Lu M, Jesse MT. Influence of Acuity Circles on Hepatocellular Carcinoma and the Interaction of Gender and Race in Liver Transplantation. Clin Transplant. 2024 Dec; 38(12):e70045. PMID: 39620868.
      Citations:    Fields:    Translation:Humans
    4. Sandella R, Pillai A, Pillai A. A history of transplant oncology-The story of Steve Jobs. Liver Transpl. 2025 Apr 01; 31(4):545-547. PMID: 39621057.
      Citations:    Fields:    
    5. Yu Q, Mahbubani A, Kwak D, Liao CY, Pillai A, Patel M, Navuluri R, Funaki B, Ahmed O, Yu Q, Mahbubani A, Kwak D, Liao CY, Pillai A, Patel M, Navuluri R, Funaki B, Ahmed O. Survival Outcomes of Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database: Comparison with Radiotherapy and Resection. J Vasc Interv Radiol. 2025 Mar; 36(3):489-498.e3. PMID: 39491643.
      Citations:    Fields:    
    6. Gujarathi R, Klein JA, Liao CY, Pillai A. The Changing Demographics and Epidemiology of Hepatocellular Carcinoma. Clin Liver Dis. 2025 Feb; 29(1):1-15. PMID: 39608950.
      Citations:    Fields:    Translation:Humans
    7. Sandella R, Wollstein Y, Pillai A. Guidelines in Practice: Focal Liver Lesions. Am J Gastroenterol. 2024 Oct 21. PMID: 39436238.
      Citations:    Fields:    
    8. Park S, Davis AM, Pillai AA. Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024 09 24; 332(12):1013-1014. PMID: 39207780.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Fulgenzi CAM, Scheiner B, D'Alessio A, Mehan A, Manfredi GF, Celsa C, Nishida N, Ang C, Marron TU, Wu L, Saeed A, Wietharn B, Cammarota A, Pressiani T, Pinter M, Sharma R, Cheon J, Huang YH, Lee PC, Phen S, Gampa A, Pillai A, Napolitano A, Vivaldi C, Salani F, Masi G, Silletta M, Lo Prinzi F, Di Giacomo E, Vincenzi B, Bettinger D, Thimme R, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Pirisi M, Park JW, Kudo M, Rimassa L, Singal AG, El Tomb P, Ulahannan S, Parisi A, Chon HJ, Hsu WF, Ghittoni G, Cammà C, Stefanini B, Trevisani F, Giannini EG, Cortellini A, Pinato DJ. Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction. JAMA Oncol. 2024 Sep 01; 10(9):1253-1258. PMID: 39023864; PMCID: PMC11258634.
      Citations: 1     Fields:    Translation:Humans
    10. Gujarathi R, Franses JW, Pillai A, Liao CY. Targeted therapies in hepatocellular carcinoma: past, present, and future. Front Oncol. 2024; 14:1432423. PMID: 39267840; PMCID: PMC11390354.
      Citations:    
    11. Lim N, Devuni D, German M, Guy J, Rabiee A, Sharma P, Shingina A, Shroff H, Pillai A. The rise of multidisciplinary clinics in hepatology: A practical, how-to-guide, and review of the literature. Hepatology. 2024 Jul 30. PMID: 39212328.
      Citations:    Fields:    
    12. Parikh ND, Jones P, Salgia R, Bhan I, Grinspan LT, Jou JH, Zhou K, Jalal P, Roccaro G, Rangnekar AS, Benhammou JN, Pillai A, Mehta N, Wedd J, Yang JD, Kim AK, Duarte-Rojo A, Oloruntoba OO, Tevar A, Au JS, Blain Y, Rao S, Catalano OA, Lewis S, Mendiratta-Lala M, King K, Sachdev L, Lee EW, Bruno J, Kamel I, Tolosa C, Kao K, Badawi T, Przybyszewski EM, Quirk L, Nathani P, Haydel B, Leven E, Wong N, Albertian R, Chen A, Aloor FZ, Mohamed IB, Elkheshen A, Marvil C, Issac G, Clinton JW, Woo SM, Yum J, Rieger E, Hutchison AL, Turner DA, Alsudaney M, Hernandez P, Xu Z, Khalid A, Barrick B, Wang B, Tapper EB, Hao W, Singal AG, Parikh ND, Jones P, Salgia R, Bhan I, Grinspan LT, Jou JH, Zhou K, Jalal P, Roccaro G, Rangnekar AS, Benhammou JN, Pillai A, Mehta N, Wedd J, Yang JD, Kim AK, Duarte-Rojo A, Oloruntoba OO, Tevar A, Au JS, Blain Y, Rao S, Catalano OA, Lewis S, Mendiratta-Lala M, King K, Sachdev L, Lee EW, Bruno J, Kamel I, Tolosa C, Kao K, Badawi T, Przybyszewski EM, Quirk L, Nathani P, Haydel B, Leven E, Wong N, Albertian R, Chen A, Aloor FZ, Mohamed IB, Elkheshen A, Marvil C, Issac G, Clinton JW, Woo SM, Yum J, Rieger E, Hutchison AL, Turner DA, Alsudaney M, Hernandez P, Xu Z, Khalid A, Barrick B, Wang B, Tapper EB, Hao W, Singal AG, Parikh ND, Jones P, Salgia R, Bhan I, Grinspan LT, Jou JH, Zhou K, Jalal P, Roccaro G, Rangnekar AS, Benhammou JN, Pillai A, Mehta N, Wedd J, Yang JD, Kim AK, Duarte-Rojo A, Oloruntoba OO, Tevar A, Au JS, Blain Y, Rao S, Catalano OA, Lewis S, Mendiratta-Lala M, King K, Sachdev L, Lee EW, Bruno J, Kamel I, Tolosa C, Kao K, Badawi T, Przybyszewski EM, Quirk L, Nathani P, Haydel B, Leven E, Wong N, Albertian R, Chen A, Aloor FZ, Mohamed IB, Elkheshen A, Marvil C, Issac G, Clinton JW, Woo SM, Yum J, Rieger E, Hutchison AL, Turner DA, Alsudaney M, Hernandez P, Xu Z, Khalid A, Barrick B, Wang B, Tapper EB, Hao W, Singal AG. Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2025 Feb; 23(2):281-290.e4. PMID: 39089513.
      Citations:    Fields:    
    13. Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, Enea M, Scheiner B, D'Alessio A, Manfredi GF, Stefanini B, Nishida N, Galle PR, Schulze K, Wege H, Ciccia R, Hsu WF, Vivaldi C, Wietharn B, Lin RP, Pirozzi A, Pressiani T, Dalbeni A, Natola LA, Auriemma A, Rigamonti C, Burlone M, Parisi A, Huang YH, Lee PC, Ang C, Marron TU, Pinter M, Cheon J, Phen S, Singal AG, Gampa A, Pillai A, Roehlen N, Thimme R, Vogel A, Soror N, Ulahannan S, Sharma R, Sacerdoti D, Pirisi M, Rimassa L, Lin CY, Saeed A, Masi G, Schönlein M, von Felden J, Kudo M, Cortellini A, Chon HJ, Cammà C, Pinato DJ, Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, Enea M, Scheiner B, D'Alessio A, Manfredi GF, Stefanini B, Nishida N, Galle PR, Ciccia R, Hsu WF, Vivaldi C, Pirozzi A, Pressiani T, Huang YH, Lee PC, Ang C, Pinter M, Gampa A, Pillai A, Roehlen N, Thimme R, Vogel A, Soror N, Ulahannan S, Sharma R, Rimassa L, Masi G, Kudo M, Cortellini A, Cammà C, Pinato DJ. Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology. 2025 Mar 01; 81(3):837-852. PMID: 39028886.
      Citations: 2     Fields:    
    14. Singal AG, Yarchoan M, Yopp A, Sapisochin G, Pinato DJ, Pillai A. Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future. Hepatol Commun. 2024 06 01; 8(6). PMID: 38829199; PMCID: PMC11150030.
      Citations: 3     Fields:    Translation:Humans
    15. Nikzad N, Fisher AR, Pillai A, Targownik LE, Te HS, Aronsohn A, Paul S. Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation. Am J Transplant. 2024 Sep; 24(9):1567-1572. PMID: 38729612.
      Citations: 1     Fields:    Translation:Humans
    16. Hutchison AL, Reddy KG, Paul S, Pillai AA. Geographic opportunities for growth in the transplant hepatology training workforce. Liver Transpl. 2024 Oct 01; 30(10):1091-1094. PMID: 38647428.
      Citations: 1     Fields:    Translation:Humans
    17. Tapper EB, Warner MA, Emamaullee J, Dunbar NM, Sholzberg M, Soto RJ, Sarwar A, Pillai A, Reyner K, Mehta S, Caldwell S, Shah RP, Poston JN, Ghabril M, Morgan TR. Management of coagulopathy among patients with cirrhosis undergoing upper endoscopy and paracentesis: Persistent gaps and areas of consensus in a multispecialty Delphi. Hepatology. 2024 08 01; 80(2):488-499. PMID: 38557474.
      Citations:    Fields:    Translation:Humans
    18. Patel MV, Pillai AA. Editorial: Role of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma. J Clin Exp Hepatol. 2024 May-Jun; 14(3):101402. PMID: 38586435; PMCID: PMC10998240.
      Citations:    
    19. Sharma P, Shenoy A, Shroff H, Kwong A, Lim N, Pillai A, Devuni D, Haque LY, Balliet W, Serper M. Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities. Liver Transpl. 2024 Aug 01; 30(8):848-861. PMID: 38471008.
      Citations: 1     Fields:    Translation:Humans
    20. Yu Q, Wang Y, Ungchusri E, Pillai A, Liao CY, Fung J, DiSabato D, Baker T, Patel M, Van Ha T, Ahmed O. Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors. J Vasc Interv Radiol. 2024 Jul; 35(7):989-997.e2. PMID: 38490364.
      Citations:    Fields:    Translation:Humans
    21. Arvind A, Seif El Dahan K, Malhotra R, Daher D, Rich NE, Patel MS, VanWagner LB, Lieber SR, Cotter TG, Louissaint J, Mufti AR, Kulik L, Pillai A, Parikh ND, Singal AG. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis. Liver Transpl. 2024 Jun 01; 30(6):595-606. PMID: 38466889.
      Citations:    Fields:    Translation:Humans
    22. Yu Q, Neale M, Ungchusri E, Rothenberger NJ, Liao C, Patel M, Pillai A, Navuluri R, Ahmed O, Ha TV. Tumor Size and Watershed Area Correlate with Incomplete Treatment and Tumor Progression after Selective Radioembolization for Hepatocellular Carcinoma. J Vasc Interv Radiol. 2024 May; 35(5):712-721.e3. PMID: 38336031.
      Citations:    Fields:    Translation:Humans
    23. Frenette C, Mendiratta-Lala M, Salgia R, Wong RJ, Sauer BG, Pillai A, Pillai A. ACG Clinical Guideline: Focal Liver Lesions. Am J Gastroenterol. 2024 07 01; 119(7):1235-1271. PMID: 38958301.
      Citations: 3     Fields:    Translation:Humans
    24. Celsa C, Cabibbo G, Scheiner B, Manfredi GF, Nishida N, Ang C, Marron TU, Saeed A, Wietharn B, Pinter M, Huang YH, Lee PC, Phen S, Gampa A, Pillai A, Vivaldi C, Salani F, Masi G, Roehlen N, Thimme R, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Galle PR, Kudo M, Rimassa L, Singal AG, El Tomb P, Ulahannan S, Parisi A, Hsu WF, Verzoni E, Giusti R, Veccia A, Catino A, Aprile G, Guglielmini PF, Di Napoli M, Antonuzzo L, Rossi E, Verderame F, Zustovich F, Ficorella C, Di Pietro FR, Battelli N, Negrini G, Grossi F, Bordonaro R, Pipitone S, Banzi M, Ricciardi S, Laera L, Russo A, De Giorgi U, Cavanna L, Sorarù M, Montesarchio V, Bordi P, Brunetti L, Pinto C, Bersanelli M, Cammà C, Cortellini A, Pinato DJ, Fulgenzi CAM, D'Alessio A, Cheon J, Chon HJ, Stefanini B, Ermacora P. Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours. J Hepatol. 2024 Mar; 80(3):431-442. PMID: 37972660.
      Citations: 9     Fields:    
    25. Dharmapuri S, Özbek U, Jethra H, Jun T, Marron TU, Saeed A, Huang YH, Muzaffar M, Pinter M, Balcar L, Fulgenzi C, Amara S, Weinmann A, Personeni N, Scheiner B, Pressiani T, Navaid M, Bengsch B, Paul S, Khan U, Bettinger D, Nishida N, Mohamed YI, Vogel A, Gampa A, Korolewicz J, Cammarota A, Kaseb A, Galle PR, Pillai A, Wang YH, Cortellini A, Kudo M, D'Alessio A, Rimassa L, Pinato DJ, Ang C. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma. World J Gastrointest Oncol. 2023 Nov 15; 15(11):1900-1912. PMID: 38077640; PMCID: PMC10701235.
      Citations: 2     
    26. Odenwald MA, Lin H, Lehmann C, Dylla NP, Cole CG, Mostad JD, Pappas TE, Ramaswamy R, Moran A, Hutchison AL, Stutz MR, Dela Cruz M, Adler E, Boissiere J, Khalid M, Cantoral J, Haro F, Oliveira RA, Waligurski E, Cotter TG, Light SH, Beavis KG, Sundararajan A, Sidebottom AM, Reddy KG, Paul S, Pillai A, Te HS, Rinella ME, Charlton MR, Pamer EG, Aronsohn AI. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049. PMID: 37845315; PMCID: PMC11059310.
      Citations: 7     Fields:    Translation:HumansAnimals
    27. Yu Q, Ungchusri E, Pillai A, Liao CY, Baker T, Fung J, DiSabato D, Zhang M, Liao C, Van Ha T, Ahmed O. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma. Eur Radiol. 2024 Apr; 34(4):2374-2383. PMID: 37812295.
      Citations: 1     Fields:    Translation:Humans
    28. Singal AG, Pillai A, Parikh ND. INASL Consensus on Management of HCC: Navigating an Evolving Field. J Clin Exp Hepatol. 2024 Jan-Feb; 14(1):101292. PMID: 38076368; PMCID: PMC10709166.
      Citations:    
    29. Hunold T, Pillai A. Current updates in HCC screening and treatment. Clin Liver Dis (Hoboken). 2023 Oct; 22(4):122-129. PMID: 37908865; PMCID: PMC10615533.
      Citations: 1     
    30. Yu Q, Khanjyan M, Fidelman N, Pillai A. Contemporary applications of Y90 for the treatment of hepatocellular carcinoma. Hepatol Commun. 2023 10 01; 7(10). PMID: 37782464; PMCID: PMC10545406.
      Citations: 3     Fields:    Translation:Humans
    31. Yu Q, Wang Y, Ungchusri E, Patel M, Kumari D, Van Ha T, Pillai A, Liao CY, Ahmed O. Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility. J Interv Med. 2023 Nov; 6(4):187-193. PMID: 38312131; PMCID: PMC10831372.
      Citations: 6     
    32. Kulkarni AV, Tevethia H, Kumar K, Premkumar M, Muttaiah MD, Hiraoka A, Hatanaka T, Tada T, Kumada T, Kakizaki S, Vogel A, Finn RS, Rao PN, Pillai A, Reddy DN, Singal AG. Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis. EClinicalMedicine. 2023 Sep; 63:102179. PMID: 37680945; PMCID: PMC10480543.
      Citations: 7     
    33. Odenwald MA, Roth HF, Reticker A, Segovia M, Pillai A. Evolving challenges with long-term care of liver transplant recipients. Clin Transplant. 2023 10; 37(10):e15085. PMID: 37545440.
      Citations: 3     Fields:    Translation:Humans
    34. Yu Q, Patel M, Kwak D, Ungchusri E, Wang Y, Van Ha T, Zangan S, Marshall E, Little K, Baker T, Liao CY, Pillai A, Ahmed O. Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience. J Vasc Interv Radiol. 2023 11; 34(11):1970-1976.e1. PMID: 37532096.
      Citations: 1     Fields:    Translation:Humans
    35. Patel M, Pillai A. Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy. Surg Oncol Clin N Am. 2024 01; 33(1):159-172. PMID: 37945141.
      Citations: 1     Fields:    Translation:Humans
    36. Winters AC, Aby ES, Pourmand K, Barman P, Kriss M, Pillai A. Many transplant hepatology graduates feel unprepared for first job search: Results from a national employment survey of early career hepatologists. Liver Transpl. 2023 12 01; 29(12):1332-1336. PMID: 37309214.
      Citations:    Fields:    Translation:Humans
    37. Pillai A, Goldaracena N, Rosenblatt R, Verna EC. CAQ Corner: Evaluation and management of living liver donors. Liver Transpl. 2023 10 01; 29(10):1118-1128. PMID: 37243369.
      Citations:    Fields:    
    38. Aby ES, Pillai A. HiCCups in management-Pitfalls and pearls for the management of HCC. Clin Liver Dis (Hoboken). 2023 Sep; 22(3):85-88. PMID: 37799639; PMCID: PMC10550015.
      Citations:    
    39. Sturdevant M, Ganesh S, Samstein B, Verna EC, Rodriguez-Davalos M, Kumar V, Abouljoud M, Andacoglu O, Askar M, Broering D, Emamaullee J, Emond JC, Haugen CE, Jesse MT, Kasahara M, Liapakis A, Mandelbrot D, Pillai A, Roll GR, Selzner N, Emre S, AST LDLT Consensus Conference Working Group. Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14968. PMID: 37039541.
      Citations: 1     Fields:    Translation:Humans
    40. Verna EC, Sapisochin G, Selzner N, Mathur A, Perito ER, Pillai A, Parikh ND, Cooper M, Thiessen C, Heimbach J, Gordon EJ, Jesse M, Liapakis A, Kumar V, AST LDLT Consensus Conference Working Group. Financial, policy, and ethical barriers to the expansion of living donor liver transplant: Meeting report from a living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14955. PMID: 36880375.
      Citations: 1     Fields:    Translation:Humans
    41. Emre S, Verna EC, Liapakis A, Jesse MT, Pillai A, Bittermann T, Dew MA, Hunt H, Kumar V, Locke J, Mohammad S, Olthoff K, Lentine KL, LDLT Consensus Conference Working Group. Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in culture. Clin Transplant. 2023 07; 37(7):e14953. PMID: 36890717.
      Citations:    Fields:    Translation:Humans
    42. Liapakis A, Agbim U, Bittermann T, Dew MA, Deng Y, Gan G, Emre S, Hunt HF, Olthoff KM, Locke JE, Jesse MT, Kumar V, Pillai A, Verna E, Lentine KL, AST LDLT Consensus Conference Working Group. A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clin Transplant. 2023 07; 37(7):e14967. PMID: 36938716.
      Citations: 1     Fields:    Translation:Humans
    43. Jesse MT, Jackson WE, Liapakis A, Ganesh S, Humar A, Goldaracena N, Levitsky J, Mulligan D, Pomfret EA, Ladner DP, Roberts JP, Mavis A, Thiessen C, Trotter J, Winder GS, Griesemer AD, Pillai A, Kumar V, Verna EC, LaPointe Rudow D, Han HH, AST LDLT Consensus Conference Working Group. Living donor liver transplant candidate and donor selection and engagement: Meeting report from the living donor liver transplant consensus conference. Clin Transplant. 2023 07; 37(7):e14954. PMID: 36892182.
      Citations: 3     Fields:    Translation:Humans
    44. Singal AG, Ghaziani TT, Mehta N, Zhou K, Grinspan LT, Benhammou JN, Moon AM, Yang JD, Salgia R, Pillai A, Zheng E, Rich NE, Gopal P, Jalal P, Verna E, Yekkaluri S, Phen S, Melendez-Torres J, Alshuwaykh O, Choi H, Junus K, Grady J, Song M, Leven EA, Yum J, Gowda V, Alsudaney M, Hernandez P, Desai N, Parikh ND. Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatol Commun. 2023 03 01; 7(3). PMID: 36881615; PMCID: PMC9995094.
      Citations: 4     Fields:    Translation:Humans
    45. Wu YL, van Hyfte G, Reincke M, Gampa A, Mohamed YI, Nishida N, Wietharn B, Amara S, Lee PC, Scheiner B, Balcar L, Pinter M, Vogel A, Weinmann A, Saeed A, Pillai A, Rimassa L, Naqash AR, Muzaffar M, Huang YH, Kaseb AO, Kudo M, Pinato DJ, Ang C, Özbek U. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors. Front Oncol. 2023; 13:1128569. PMID: 36865801; PMCID: PMC9971987.
      Citations: 2     
    46. Shingina A, Chadha R, Lim N, Pillai A, Vodkin I, Montenovo M, Heller T, Yardeni D, Ganger D. Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices. Liver Transpl. 2023 06 01; 29(6):591-597. PMID: 36745932; PMCID: PMC10191975.
      Citations:    Fields:    Translation:Humans
    47. Jackson WE, Kaplan A, Saben JL, Kriss MS, Cisek J, Samstein B, Liapakis A, Pillai AA, Brown RS, Pomfret EA. Practice patterns of the medical evaluation of living liver donors in the United States. Liver Transpl. 2023 02 01; 29(2):164-171. PMID: 36111606.
      Citations: 2     Fields:    Translation:Humans
    48. Talbot T, D'Alessio A, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Dharmapuri S, Ang C, Saeed A, Hildebrand H, Muzaffar M, Fulgenzi CAM, Amara S, Naqash AR, Gampa A, Pillai A, Wang Y, Khan U, Lee PC, Huang YH, Bengsch B, Bettinger D, Mohamed YI, Kaseb A, Pressiani T, Personeni N, Rimassa L, Nishida N, Kudo M, Weinmann A, Galle PR, Muhammed A, Cortellini A, Vogel A, Pinato DJ. Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study. Liver Int. 2023 03; 43(3):695-707. PMID: 36577703; PMCID: PMC10947007.
      Citations: 10     Fields:    Translation:Humans
    49. Ahmed O, Yu Q, Patel M, Hwang G, Pillai A, Liao CY, Fung J, Baker T. Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma. J Vasc Interv Radiol. 2023 04; 34(4):702-709. PMID: 36521794.
      Citations: 4     Fields:    Translation:Humans
    50. Gampa A, Odenwald MA, Pillai A. PRO: Coronavirus disease 2019 vaccination should be mandatory for liver transplant candidates. Clin Liver Dis (Hoboken). 2022 Nov; 20(5):151-153. PMID: 36447910; PMCID: PMC9700052.
      Citations: 1     
    51. Jackson WE, Kaplan A, Saben JL, Kriss MS, Cisek J, Samstein B, Liapakis A, Pillai AA, Brown RS, Pomfret EA. Liver Transpl. 2022 Oct 11; 164-171. PMID: 37160068.
      Citations:    Fields:    
    52. Juloori A, Katipally RR, Lemons JM, Singh AK, Iyer R, Robbins JR, George B, Hall WA, Pitroda SP, Arif F, Fung J, Pillai A, Liao CY, Sharma M, Liauw SL. Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):202-213. PMID: 36108891.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    53. Fung J, DiSabato D, Liao CY, Ahmed O, Pillai A. Perspective: Advances in liver transplantation for hepatocellular carcinoma - A prototype for transplant oncology. Hepatobiliary Pancreat Dis Int. 2023 02; 22(1):4-6. PMID: 36163102.
      Citations: 3     Fields:    Translation:Humans
    54. Lim N, Kwong AJ, Jafri SM, Jesse MT, Kriss M, Nair K, Pillai A, Shingina A, Tang Q, Desai AP. Heterogeneity in Center Practices in Liver Transplantation for Alcohol-Associated Liver Disease in the United States. Am J Gastroenterol. 2022 09 01; 117(9):1530-1535. PMID: 35916539.
      Citations: 7     Fields:    Translation:Humans
    55. Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen NN, Kim HP, Paknikar R, Rich NE, Schipper MJ, Singal AG. Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma. Cancer. 2022 10 01; 128(19):3470-3478. PMID: 35796530; PMCID: PMC9545187.
      Citations: 5     Fields:    Translation:HumansCells
    56. Marinelli B, Kim E, D'Alessio A, Cedillo M, Sinha I, Debnath N, Kudo M, Nishida N, Saeed A, Hildebrand H, Kaseb AO, Abugabal YI, Pillai A, Huang YH, Khan U, Muzaffar M, Naqash AR, Patel R, Fischman A, Bishay V, Bettinger D, Sung M, Ang C, Schwartz M, Pinato DJ, Marron T. Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study. J Immunother Cancer. 2022 06; 10(6). PMID: 35710293; PMCID: PMC9204420.
      Citations: 17     Fields:    Translation:Humans
    57. Pillai AA, Kriss M, Al-Adra DP, Chadha RM, Cushing MM, Farsad K, Fortune BE, Hess AS, Lewandowski R, Nadim MK, Nydam T, Sharma P, Karvellas CJ, Intagliata N. Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care. Liver Transpl. 2022 10; 28(10):1651-1663. PMID: 35253365; PMCID: PMC9790275.
      Citations: 4     Fields:    Translation:Humans
    58. Sharma R, Pillai A, Marron TU, Fessas P, Saeed A, Jun T, Dharmapuri S, Szafron D, Naqash AR, Gampa A, Wang Y, Khan U, Muzaffar M, Lee CJ, Lee PC, Bulumulle A, Paul S, Bettinger D, Hildebrand H, Yehia M, Pressiani T, Kaseb A, Huang YH, Ang C, Kudo M, Nishida N, Personeni N, Rimassa L, Pinato DJ. Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC. Hepatol Commun. 2022 07; 6(7):1776-1785. PMID: 35481940; PMCID: PMC9234627.
      Citations: 8     Fields:    Translation:Humans
    59. Aniemeka C, Pillai AA. HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV. Dig Dis Sci. 2022 08; 67(8):3483-3484. PMID: 35288830.
      Citations: 1     Fields:    Translation:Humans
    60. Wang J, Pillai AA. Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Aliment Pharmacol Ther. 2022 02; 55(4):479-480. PMID: 35092049.
      Citations:    Fields:    Translation:Humans
    61. Hutchison AL, Cifu AS, Pillai AA. Discarding Dichotomization: Retrieving Data in the Service of Patient Care. Clin Liver Dis (Hoboken). 2022 Jan; 19(1):12-16. PMID: 35106143; PMCID: PMC8785915.
      Citations:    
    62. Muhammed A, Fulgenzi CAM, Dharmapuri S, Pinter M, Balcar L, Scheiner B, Marron TU, Jun T, Saeed A, Hildebrand H, Muzaffar M, Navaid M, Naqash AR, Gampa A, Ozbek U, Lin JY, Perone Y, Vincenzi B, Silletta M, Pillai A, Wang Y, Khan U, Huang YH, Bettinger D, Abugabal YI, Kaseb A, Pressiani T, Personeni N, Rimassa L, Nishida N, Di Tommaso L, Kudo M, Vogel A, Mauri FA, Cortellini A, Sharma R, D'Alessio A, Ang C, Pinato DJ. The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers (Basel). 2021 Dec 31; 14(1). PMID: 35008350; PMCID: PMC8750517.
      Citations: 42     
    63. Desai N, Pillai AA. The New Era of Liver Transplantation for Cholangiocarcinoma: No Longer Just a 1-Man Show. Liver Transpl. 2022 03; 28(3):355-356. PMID: 34826202.
      Citations:    Fields:    Translation:Humans
    64. Fessas P, Naeem M, Pinter M, Marron TU, Szafron D, Balcar L, Saeed A, Jun T, Dharmapuri S, Gampa A, Wang Y, Khan U, Muzaffar M, Navaid M, Lee PC, Bulumulle A, Yu B, Paul S, Nimkar N, Bettinger D, Hildebrand H, Abugabal YI, Pressiani T, Personeni N, Nishida N, Kudo M, Kaseb A, Huang YH, Ang C, Pillai A, Rimassa L, Naqash AR, Sharon E, Cortellini A, Pinato DJ. Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma. Liver Cancer. 2021 Nov; 10(6):583-592. PMID: 34950181; PMCID: PMC8647090.
      Citations: 24     
    65. Pinato DJ, Marron TU, Mishra-Kalyani PS, Gong Y, Wei G, Szafron D, Sharon E, Saeed A, Jun T, Dharmapuri S, Naqash AR, Peeraphatdit T, Gampa A, Wang Y, Khan U, Muzaffar M, Navaid M, Lee CJ, Lee PC, Bulumulle A, Yu B, Paul S, Nimkar N, Bettinger D, Hildebrand H, Abugabal YI, Pressiani T, Personeni N, D'Alessio A, Kaseb AO, Huang YH, Ang C, Schneider J, Pillai A, Rimassa L, Goldberg KB, Pazdur R, Theoret M, Lemery S, Fashoyin-Aje ', Cortellini A, Pelosof L. Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice. Eur J Cancer. 2021 11; 157:140-152. PMID: 34508996.
      Citations: 26     Fields:    Translation:Humans
    66. Aby ES, Kriss M, Rubin DT, Pillai A. How to Navigate National Societal Organizations for Leadership Development and Academic Promotion: A Guide for Trainees and Young Faculty. Gastroenterology. 2021 11; 161(5):1361-1365. PMID: 34464630.
      Citations: 1     Fields:    Translation:Humans
    67. Mikolajczyk AE, Zilberstein N, McConville JF, Pan A, Aronsohn AI, Te HS, Reddy G, Paul S, Pillai A, Charlton M, Farnan JM. Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs. Hepatol Commun. 2021 11; 5(11):1953-1963. PMID: 34558840; PMCID: PMC8557317.
      Citations: 1     Fields:    Translation:Humans
    68. Yu Q, Liu C, Pillai A, Ahmed O. Twenty Years of Radiation Therapy of Unresectable Intrahepatic Cholangiocarinoma: Internal or External? A Systematic Review and Meta-Analysis. Liver Cancer. 2021 Sep; 10(5):433-450. PMID: 34721506; PMCID: PMC8527917.
      Citations: 6     
    69. Cotter TG, Minhem M, Wang J, Peeraphatdit T, Ayoub F, Pillai A, Hernandez-Alejandro R, di Sabato D, Charlton M. Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes. Liver Transpl. 2021 07; 27(7):1019-1031. PMID: 33619854; PMCID: PMC9257956.
      Citations: 18     Fields:    Translation:Humans
    70. Parikh ND, Pillai A. Recent Advances in Hepatocellular Carcinoma Treatment. Clin Gastroenterol Hepatol. 2021 10; 19(10):2020-2024. PMID: 34116048.
      Citations: 23     Fields:    Translation:Humans
    71. Wang J, Pillai A. Systemic Therapy for Hepatocellular Carcinoma. Clin Liver Dis (Hoboken). 2021 May; 17(5):337-340. PMID: 34136138; PMCID: PMC8177835.
      Citations: 3     
    72. Hutchison AL, Pillai A. The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps. Curr Opin Organ Transplant. 2021 06 01; 26(3):339-345. PMID: 33938470.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    73. Patel P, Pillai A. Liver Transplantation Services During the Time of COVID-19. J Clin Transl Hepatol. 2021 Aug 28; 9(4):587-591. PMID: 34447689; PMCID: PMC8369007.
      Citations:    
    74. Woolen SA, Singal AG, Davenport MS, Troost JP, Khalatbari S, Mittal S, Siddiqui S, Fobar A, Morris J, Odewole M, Tapper EB, Pillai A, Parikh ND. Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters. Clin Gastroenterol Hepatol. 2022 01; 20(1):204-215.e6. PMID: 33618022; PMCID: PMC9150784.
      Citations: 26     Fields:    Translation:Humans
    75. Aitcheson G, Pillai A, Dahman B, John BV. Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma. Curr Hepatol Rep. 2021; 20(1):23-33. PMID: 33552839; PMCID: PMC7848044.
      Citations: 7     
    76. Badar W, Van Ha T, Zangan S, Navuluri R, Pillai A, Baker T, Dalag L, Han R, Ahmed O. Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory. Br J Radiol. 2021 Mar 01; 94(1119):20200752. PMID: 33411569; PMCID: PMC8011251.
      Citations: 6     Fields:    Translation:Humans
    77. Patel P, Wang J, Pillai A. CON: Liver Transplant Should Not Be Performed in Patients With Acute Alcoholic Hepatitis. Clin Liver Dis (Hoboken). 2020 Nov; 16(5):182-185. PMID: 33318784; PMCID: PMC7727858.
      Citations: 1     
    78. Pillai A, Ahn J, Kulik L. Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead. Am J Gastroenterol. 2020 12; 115(12):1960-1969. PMID: 33038134.
      Citations: 9     Fields:    Translation:Humans
    79. Pillai AA, Ramanathan M, Kulik L. Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years? Clin Liver Dis. 2020 11; 24(4):681-700. PMID: 33012453.
      Citations: 3     Fields:    Translation:Humans
    80. Ahmed O, Pillai A. Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy. Am J Gastroenterol. 2020 11; 115(11):1733-1736. PMID: 33156085.
      Citations: 3     Fields:    Translation:Humans
    81. Ferrante ND, Pillai A, Singal AG. Update on the Diagnosis and Treatment of Hepatocellular Carcinoma. Gastroenterol Hepatol (N Y). 2020 Oct; 16(10):506-516. PMID: 34017223; PMCID: PMC8132669.
      Citations: 26     
    82. Ahmed O, Pillai A. Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy. Am J Gastroenterol. 2020 Sep 30. PMID: 33009058.
      Citations:    
    83. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2022 01; 20(1):183-193. PMID: 32927050; PMCID: PMC8657369.
      Citations: 11     Fields:    Translation:Humans
    84. Cotter TG, Paul S, Gampa A, Wang J, Te H, Pillai A, Reddy KG, di Sabato D, Little EC, Sundaram V, Fung J, Lucey MR, Charlton M, Sandikçi B. Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency. Am J Transplant. 2021 03; 21(3):1039-1055. PMID: 32531107.
      Citations: 25     Fields:    Translation:Humans
    85. Badar W, Van Ha T, Zangan S, Navuluri R, Pillai A, Baker T, Ahmed O. Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma. Gastrointest Tumors. 2020 Oct; 7(4):144-150. PMID: 33173778; PMCID: PMC7590772.
      Citations: 2     
    86. Lin A, Alpert L, Hart J, Chapman C, Pillai AA. Lymphoepithelioma-Like Carcinomas: A Rare Variant of Cholangiocarcinoma. Hepatology. 2020 07; 72(1):353-355. PMID: 31904867.
      Citations: 8     Fields:    Translation:Humans
    87. Parikh N, Pillai A. Positron Emission Tomography With Computed Tomography as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma: Ready for Prime Time? Liver Transpl. 2020 06; 26(6):746-747. PMID: 32286722.
      Citations:    Fields:    Translation:Humans
    88. Ahmed O, Salaskar AL, Zangan S, Pillai A, Baker T. Transsplenic portal vein recanalization and direct intrahepatic portosystemic shunt placement to optimize liver transplantation. CVIR Endovasc. 2020 Jan 08; 3(1):5. PMID: 32026045; PMCID: PMC6966405.
      Citations: 1     
    89. Verna EC, Patel YA, Aggarwal A, Desai AP, Frenette C, Pillai AA, Salgia R, Seetharam A, Sharma P, Sherman C, Tsoulfas G, Yao FY. Liver transplantation for hepatocellular carcinoma: Management after the transplant. Am J Transplant. 2020 02; 20(2):333-347. PMID: 31710773.
      Citations: 59     Fields:    Translation:Humans
    90. Cotter TG, Pillai AA. Consult for Portal Vein Thrombosis. Clin Liver Dis (Hoboken). 2019 Aug; 14(2):74-77. PMID: 31508225; PMCID: PMC6726384.
      Citations: 3     
    91. Singal AG, Rich NE, Mehta N, Branch AD, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2. PMID: 31374215; PMCID: PMC6815711.
      Citations: 61     Fields:    Translation:Humans
    92. Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette CT, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983. PMID: 31357028; PMCID: PMC8174017.
      Citations: 10     Fields:    Translation:Humans
    93. Mikolajczyk A, Yassan L, Pillai A. Approach to Evaluation of Multiple Liver Lesions-Reply. JAMA. 2019 05 28; 321(20):2031-2032. PMID: 31135844.
      Citations:    Fields:    Translation:Humans
    94. Pillai A, Couri T, Charlton M. Liver Allocation Policies in the USA: Past, Present, and the Future. Dig Dis Sci. 2019 04; 64(4):985-992. PMID: 30895482.
      Citations: 7     Fields:    Translation:Humans
    95. Couri T, Harmath C, Baker T, Pillai A. Acute portal vein thrombosis after liver transplant presenting with subtle ultrasound abnormalities: A case report and literature review. World J Hepatol. 2019 Feb 27; 11(2):234-241. PMID: 30820273; PMCID: PMC6393712.
      Citations:    
    96. Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1. PMID: 30660729; PMCID: PMC6598433.
      Citations: 66     Fields:    Translation:Humans
    97. Mikolajczyk AE, Yassan LJ, Pillai AA. A Patient With an Elevated a-Fetoprotein Level and Liver Masses. JAMA. 2019 Jan 01; 321(1):97-98. PMID: 30543371.
      Citations:    Fields:    Translation:Humans
    98. Couri T, Pillai A. Goals and targets for personalized therapy for HCC. Hepatol Int. 2019 Mar; 13(2):125-137. PMID: 30600478.
      Citations: 271     Fields:    Translation:Humans
    99. Pillai A. Mixed Hepatocellular-Cholangiocarcinoma: Is It Time to Rethink Consideration for Liver Transplantation? Liver Transpl. 2018 10; 24(10):1329-1330. PMID: 30118151.
      Citations:    Fields:    Translation:Humans
    100. Spengler EK, O'Leary JG, Te HS, Rogal S, Pillai AA, Al-Osaimi A, Desai A, Fleming JN, Ganger D, Seetharam A, Tsoulfas G, Montenovo M, Lai JC. Liver Transplantation in the Obese Cirrhotic Patient. Transplantation. 2017 10; 101(10):2288-2296. PMID: 28930104; PMCID: PMC5762611.
      Citations: 32     Fields:    Translation:Humans
    101. Pillai AA, Maheshwari R, Vora R, Norvell JP, Ford R, Parekh S, Cheng N, Patel A, Young N, Spivey JR, Mgbemena O, Wedd JP. Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin. Aliment Pharmacol Ther. 2017 06; 45(11):1427-1432. PMID: 28382751.
      Citations: 8     Fields:    Translation:HumansCells
    102. Pillai AA, Anania FA, Pearlman BL. Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy. Am J Gastroenterol. 2016 Dec; 111(12):1854-1856. PMID: 27924099; PMCID: PMC5764166.
      Citations: 2     Fields:    Translation:Humans
    103. Ahn J, Lim JK, Lee HM, Lok AS, Nguyen M, Pan CQ, Mannalithara A, Te H, Reddy KR, Trinh H, Chu D, Tran T, Lau D, Leduc TS, Min A, Trong Le L, Bae H, Van Tran S, Do S, Hann HW, Wong C, Han S, Pillai A, Park JS, Tong M, Scaglione S, Woog J, Kim WR. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. Am J Gastroenterol. 2016 09; 111(9):1297-304. PMID: 27325221.
      Citations: 16     Fields:    Translation:Humans
    104. Pillai AA, Wedd J, Norvell JP, Parekh S, Cheng N, Young N, Spivey JR, Ford R. Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience. Am J Gastroenterol. 2016 Feb; 111(2):250-60. PMID: 26832650.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    105. Nair KM, Pillai A, Huguenard AL. Obscure Gastrointestinal Bleeding in the Setting of Portal Hypertension. J Clin Gastroenterol. 2016 Jan; 50(1):92-3. PMID: 26501881.
      Citations:    Fields:    Translation:Humans
    106. Kathpalia P, Bhatia A, Robertazzi S, Ahn J, Cohen SM, Sontag S, Luke A, Durazo-Arvizu R, Pillai AA. Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites. Intern Med J. 2015 Oct; 45(10):1026-31. PMID: 26122531.
      Citations: 10     Fields:    Translation:Humans
    107. Xing M, Webber G, Prajapati HJ, Chen Z, El-Rayes B, Spivey JR, Pillai AA, Kim HS. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study. J Gastroenterol Hepatol. 2015 Jul; 30(7):1167-74. PMID: 25675849.
      Citations: 9     Fields:    Translation:Humans
    108. Collins JM, Raphael KL, Terry C, Cartwright EJ, Pillai A, Anania FA, Farley MM. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir. Clin Infect Dis. 2015 Oct 15; 61(8):1304-6. PMID: 26082511.
      Citations: 44     Fields:    Translation:HumansCells
    109. Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumberg E, Avery RK, Koval C, Lease ED, Pillai A, Doucette KE, Levitsky J, Morris MI, Lu K, McDermott JK, Mone T, Orlowski JP, Dadhania DM, Abbott K, Horslen S, Laskin BL, Mougdil A, Venkat VL, Korenblat K, Kumar V, Grossi P, Bloom RD, Brown K, Kotton CN, Kumar D. Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant. 2015 May; 15(5):1162-72. PMID: 25707744.
      Citations: 57     Fields:    Translation:HumansCells
    110. Pillai AA. Management of de novo malignancies after liver transplantation. Transplant Rev (Orlando). 2015 Jan; 29(1):38-41. PMID: 25510578.
      Citations: 3     Fields:    Translation:Humans
    111. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med. 2014 Apr; 11(4):e1001624. PMID: 24691105; PMCID: PMC3972088.
      Citations: 335     Fields:    Translation:HumansPHPublic Health
    112. Pillai AA, Lee VS, Wang E, Rinella ME, Levitsky J. Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C. Transplant Proc. 2010 Nov; 42(9):3647-51. PMID: 21094833.
      Citations:    Fields:    Translation:HumansCells
    113. Pillai AA, Rinella ME. Non-alcoholic fatty liver disease: is bariatric surgery the answer? Clin Liver Dis. 2009 Nov; 13(4):689-710. PMID: 19818313.
      Citations: 19     Fields:    Translation:Humans
    114. Pillai AA, Levitsky J. Overview of immunosuppression in liver transplantation. World J Gastroenterol. 2009 Sep 14; 15(34):4225-33. PMID: 19750565; PMCID: PMC2744178.
      Citations: 32     Fields:    Translation:Humans
    115. Hanouneh IA, Feldstein AE, Lopez R, Yerian L, Pillai A, Zein CO, Zein NN. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2008 May; 6(5):584-9. PMID: 18455698.
      Citations: 17     Fields:    Translation:Humans
    116. Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev. 2008 Jan 23; (1):CD004611. PMID: 18254055.
      Citations: 71     Fields:    Translation:HumansAnimalsCells
    Pillai's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (260)
    Explore
    _
    Co-Authors (35)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _